Terms: = Brain cancer AND CgA AND Treatment
11 results:
1. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
2. Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up.
Kang Z; Li S; Kang X; Deng J; Yang H; Chen F; Jiang J; Zhang J; Li W
Cancer Biol Med; 2023 Jun; 20(6):465-76. PubMed ID: 37366368
[TBL] [Abstract] [Full Text] [Related]
3. Category guided attention network for brain tumor segmentation in MRI.
Li J; Yu H; Chen C; Ding M; Zha S
Phys Med Biol; 2022 Apr; 67(8):. PubMed ID: 35354136
[No Abstract] [Full Text] [Related]
4. treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management.
Chahal M; Thiessen B; Mariano C
Curr Oncol; 2022 Jan; 29(1):360-376. PubMed ID: 35049706
[TBL] [Abstract] [Full Text] [Related]
5. Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
Ni J; Zhang X; Wang H; Si X; Xu Y; Zhao J; Chen M; Zhang L; Wang M
Thorac Cancer; 2022 Feb; 13(4):539-548. PubMed ID: 34970848
[TBL] [Abstract] [Full Text] [Related]
6. The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.
Luque RM; Ibáñez-Costa A; Sánchez-Tejada L; Rivero-Cortés E; Robledo M; Madrazo-Atutxa A; Mora M; Álvarez CV; Lucas-Morante T; Álvarez-Escolá C; Fajardo C; Castaño L; Gaztambide S; Venegas-Moreno E; Soto-Moreno A; Gálvez MÁ; Salvador J; Valassi E; Webb SM; Picó A; Puig-Domingo M; Gilabert M; Bernabéu I; Marazuela M; Leal-Cerro A; Castaño JP;
Endocrinol Nutr; 2016; 63(6):274-84. PubMed ID: 27091627
[TBL] [Abstract] [Full Text] [Related]
7. [Diagnostic and therapeutic difficulties in MEN 1 syndrome].
Krassowski J
Endokrynol Pol; 2005; 56(3):302-7. PubMed ID: 16350723
[TBL] [Abstract] [Full Text] [Related]
8. Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas.
Jin L; Kulig E; Qian X; Scheithauer BW; Young WF; Davis DH; Seidah NG; Chretien M; Lloyd RV
Pituitary; 1999 May; 1(3-4):187-95. PubMed ID: 11081197
[TBL] [Abstract] [Full Text] [Related]
9. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
[TBL] [Abstract] [Full Text] [Related]
10. Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression.
Thiny MT; Antczak C; Fields K; Jin L; Lloyd RV
Lab Invest; 1994 Jun; 70(6):899-906. PubMed ID: 7912292
[TBL] [Abstract] [Full Text] [Related]
11. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.
Jin L; Chandler WF; Smart JB; England BG; Lloyd RV
J Clin Endocrinol Metab; 1993 Mar; 76(3):728-35. PubMed ID: 7680355
[TBL] [Abstract] [Full Text] [Related]
